{"date":"2025-10-20","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4157-2025-10-20-1825-1v89vf8","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"18:25:57","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"第35款","fact_date":"2025-10-19","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-10-20 18:25，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2025-10-20-1812-1lxu0cg","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"18:12:17","subject":"公告本公司民國114年第3季財務報告董事會預計召開日期為民國114年10月28日","clause":"第31款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2025-10-20 18:12，「公告本公司民國114年第3季財務報告董事會預計召開日期為民國114年10月28日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-10-20-1755-1asszfj","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-10-20","time":"17:55:43","subject":"代子公司聚麗盈（福建）生物科技有限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-10-20 17:55，「代子公司聚麗盈（福建）生物科技有限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2025-10-20-1722-1m18bz2","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"17:22:47","subject":"公告114年第3季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：生展（8279），2025-10-20 17:22，「公告114年第3季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-10-20-1632-2pqq9m","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-10-20","time":"16:32:44","subject":"公告本公司民國114年第三季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-10-20 16:32，「公告本公司民國114年第三季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-10-20-1627-1n2wou2","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"16:27:15","subject":"公告本公司114年第三季財務報告董事會召開日期","clause":"第44款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-10-20 16:27，「公告本公司114年第三季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-10-20-1606-1icaggb","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-10-20","time":"16:06:43","subject":"本公司受邀參加國泰證券舉辦之生技企業日法說會","clause":"第30款","fact_date":"2025-10-29","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-10-20 16:06，「本公司受邀參加國泰證券舉辦之生技企業日法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-10-20-1543-10yb8rh","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"15:43:45","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-10-20 15:43，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-10-20-1540-pjv405","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-10-20","time":"15:40:59","subject":"公告本公司會計主管及發言人異動。","clause":"第11款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-10-20 15:40，「公告本公司會計主管及發言人異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-10-20-1533-wu4w9l","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"15:33:31","subject":"公告本公司受邀參加元富證券舉辦之「生技產業論壇」","clause":"第12款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-10-20 15:33，「公告本公司受邀參加元富證券舉辦之「生技產業論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-10-20-1522-1518zmd","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-10-20","time":"15:22:49","subject":"公告本公司董事長訂定現金增資認股基準日等相關事宜","clause":"第9款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-10-20 15:22，「公告本公司董事長訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-10-20-1500-1dvoufe","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"15:00:29","subject":"智擎公司宣布，研發中新藥PEP08進行之實體腫瘤第一期人體臨床試驗，第一位病患已開始接受藥物投予","clause":"第53款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-10-20 15:00，「智擎公司宣布，研發中新藥PEP08進行之實體腫瘤第一期人體臨床試驗，第一位病患已開始接受藥物投予」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-10-20-1432-ssivbo","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"14:32:36","subject":"本公司辦理減資彌補虧損致債權人公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-10-20 14:32，「本公司辦理減資彌補虧損致債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-10-20-1431-ub84r7","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"14:31:16","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-10-20 14:31，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-10-20-0827-1u3do01","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-10-20","time":"08:27:24","subject":"沙烏地阿拉伯食品藥品管理局(SFDA)授予中裕新藥愛滋病新藥Trogarzo罕見疾病藥物資格-用於治療多重抗藥性HIV-1感染的單株抗體","clause":"第53款","fact_date":"2025-10-20","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-10-20 08:27，「沙烏地阿拉伯食品藥品管理局(SFDA)授予中裕新藥愛滋病新藥Trogarzo罕見疾病藥物資格-用於治療多重抗藥性HIV-」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}